BEIJING, April 16, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it will serve as the exclusive product-appointed distribution agent for some of the world's leading medical equipment companies in bidding for multiple government procurement projects in China, the procurement projects we are bidding for are designated by these companies.
The appointed products the company is authorized for the procurement include Harmonic System from Johnson & Johnson Medical (Shanghai) Ltd., the MasterScreen™ pulmonary function testing system from CareFusion (Shanghai) Commercial and Trading Co. Ltd., ventilator from Weinmann GmbH + Co. KG, infusion pump from B. Braun Medical (Shanghai) International Trading Co., Ltd., spectrophotometer from Shimadzu (China) Co., Ltd. and portable color Doppler ultrasound, versatile anesthesia machine and multi-parameter monitor from Mindray Medical International Limited. The aggregate value of the procurement projects is expected to be approximately $21 million.
Dehaier Chairman and CEO Mr. Ping Chen stated, "With rich experience and resources in the Chinese medical equipment industry, especially with its mature sales and distribution networks across China, Dehaier has earned a strong reputation and increased product support from global medical equipment companies who seek to penetrate the vast Chinese healthcare market. Today we are excited and honored to enter into these exclusive arrangements with international medical equipment manufacturers to distribute their flagship products in China and to participate in potential government procurement projects. In the past year, the Chinese government procurement business has been one of Dehaier's major focuses. With a fast growing economy and aging population, we believe the Chinese government will continue to invest more to upgrade its healthcare system, particularly China's medical equipment. By partnering with world-renowned medical device companies, we are confident that our government procurement business will progress in 2014 and beyond. Dehaier is currently working on a preparation for the procurement biddings and expects to win them in quarters to come."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including medical devices and sleep respiratory products. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), HEYER (Germany) and Timesco (UK). Dehaier's technology is based on six patents and ten software copyrights. More information may be found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.